- GLP-1 analogue T2DM information sheet – April 2025
- GLP-1 T2DM adult pathway – November 2025
- Hyperglycaemia guideline for T2DM - April 2025
- Insulin Degludec Transfer of care July 2017
- Levemir (insulin detemir) discontinuation implementation plan
- Once Daily basal insulin titration patient information leaflet - April 2025
- Pen needles factsheet and template letter (withdrawn) – January 2026
- Prescribing and dispensing insulin safely FINAL Feb 2022
- Self-monitoring of blood glucose (SMBG) in Adults February 2025
- Sick day rules patient information leaflet - April 2025
- T2DM Glycaemic Control Management Pathway Sept 2022
- T2DM SGLTi Guidance Sept 2022
- Type 2 Diabetes Mellitus in adults - CESEL Guide
Diabetes Guidance
Continuous Glucose Monitoring (CGM)
- CGM – Community Pharmacy information sheet April 2023
- CGM – Primary care information sheet April 2023
- CGM – T1DM Guidance May 2023
- Flash glucose guidance and resources (Withdrawn) - August 2025
- Pan-London guidance for CGM in people living with T2DM – May 2025
- Reducing risks of selection errors with CGM devices Feb 2025
SEL IMOC homeAdult guidelines and pathwaysAnnual reports and work plansCardiovascular disease guidanceCommittee governanceCommittee minutesDiabetes and weight management treatmentsFormulary recommendations and position statementsLow priority products (NHS England)Paediatric guidelines and pathwaysPolicies & general guidanceRed, Amber, Green, Grey (RAGG) list definitionsSelf care (over the counter medicines)Shared care agreements and templatesTemplate letters
